APEI vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

APEI

38.5
AI Score
VS
UTI Wins

UTI

46.2
AI Score

Investment Advisor Scores

APEI

39score
Recommendation
SELL

UTI

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric APEI UTI Winner
Revenue 346.47M 661.15M UTI
Net Income 27.50M 15.54M APEI
Net Margin 7.9% 2.4% APEI
Operating Income 35.17M 19.27M APEI
ROE 8.8% 4.5% APEI
ROA 5.1% 1.7% APEI
Total Assets 537.75M 897.86M UTI
Debt/Equity 0.28 0.46 APEI
Current Ratio 3.25 1.30 APEI
Free Cash Flow 68.17M -63.50M APEI

Relative Price Performance (Last 90 Days)

APEI 1M: +18.1% · 3M: +2.4% UTI 1M: +6.1% · 3M: -42.7%

Current Technical Phase

APEI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.2 · Price: $48.86

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $21.66

Fundamentals Snapshot

Metric APEI UTI
Market Cap — —
Forward P/E 13.0 29.5
Trailing P/E 19.3 34.1
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.1% 0.0%
EPS 2.48 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.